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Mechanism Identification of Ficus Deltoidea Aqueous Extract in Rat Uterine 
Contractions
(Pengenalpastian Mekanisme Ekstrak Akues Ficus Deltoidea dalam Kontraksi Uterus)
FARAh WAhIDA IbRAhIM, NOR IDAyU DERASED, UMI ROMAIzAtUl AMIERA zAINUDIN, NIhAyAh MOhAMMAD & 
NOR FADIlAh RAJAb
AbStRACt
Ficus deltoidea or ‘mas cotek,’ is a uterotonic herb traditionally consumed by women to improve menstrual circulation, 
assist labour, remove retained placenta and treat postpartum bleeding. The aim of the study was to elucidate the mechanism 
of F. deltoidea in uterine contraction. Crude extracts from 2 different variants of F. deltoidea were used in the study; F. 
deltoidea var. Deltoidea (FDD) and F. deltoidea var. Angustifolia (FDA). This study was conducted ex vivo on the strips of 
isolated rats uterus treated with either FDD or FDA aqueous extract with increasing concentrations ranging from 10 µg/
ml until 1280 µg/ml at time intervals of 5 minutes between doses. The frequency and intensity of the uterine contractions 
were monitored via Powerlab software. Maximum contractions for both extracts were identified, recorded and the uterine 
strips samples at maximum contraction were selected and homogenized in order determine the role of prostaglandin 
F2α (PGF2α) in the mechanism of uterine contraction. Other than that, phosphorylated 42/44 (p42/44) of mitogen 
activated protein kinase (MAPK) expression was also detected via immunoblotting. The results showed that the maximum 
contraction induced by FDD was at the concentration of 320 µg/ml, whereas for FDA was at 960 µg/ml. Both FDD and 
FDA increased the intensity of uterine strips contractions and there were notable trend of increased PGF2α expression as 
well. Further analysis revealed that the uterine contractions involved the MAPK pathway through the phosphorylation of 
p42/44 protein. In conclusion, Ficus deltoidea of both variants have the ability to stimulate uterine contraction through 
the mechanism of MAPK pathway.
Keywords: Ficus deltoidea; uterine contraction; Mitogen Activated Protein Kinase (MAPKs); prostaglandin
AbStRAK
Ficus deltoidea atau ‘mas cotek,’ adalah herba uterotonik yang digunakan secara tradisional oleh wanita untuk 
melancarkan peredaran haid, memudahkan proses bersalin, mengeluarkan plasenta tersekat dan merawat pendarahan 
selepas bersalin. Kajian ini dijalankan untuk menentukan mekanisme F. deltoidea dalam kontraksi otot uterus. Ekstrak 
kasar daripada 2 varian F. deltoidea digunakan dalam kajian ini; F. deltoidea var. Deltoidea (FDD) dan F. deltoidea var. 
Angustifolia (FDA). Kajian ini dilakukan secara ex vivo pada sampel uterus yang dikeluarkan daripada tikus, dipotong 
membentuk jaluran dan dirawat dengan ekstrak akues FDD atau FDA dengan peningkatan kepekatan dari 10 µg/ml hingga 
1280 µg/ml dalam selang masa 5 minit antara dos. Kekerapan dan intensiti kontraksi tisu uterus dipantau melalui perisian 
Powerlab. Kontraksi maksimum bagi kedua-dua ekstrak telah dikenalpasti, direkodkan dan jaluran tisu uterus pada 
kontraksi maksimum tersebut dipilih dan dihomogenisasikan untuk menentukan peranan prostaglandin F2α (PGF2α) 
dalam mekanisme kontraksi uterus. Selain itu, pengekspresan protein terfosforilasi p42/44 daripada kumpulan mitogen 
activated protein kinase (MAPK) juga dikesan melalui kaedah pemblotan imuno. Hasil penyelidikan menunjukkan bahawa 
kontraksi maksimum yang dihasilkan oleh FDD adalah pada kepekatan 320 µg/ml, manakala untuk FDA pula adalah 
pada 960 µg/ml. Kedua-dua FDD dan FDA meningkatkan intensiti jaluran tisu uterus dan aktiviti kontraksi ini adalah 
selari dengan peningkatan PGF2α. Analisis selanjutnya menunjukkan bahawa kontraksi uterus melibatkan tapakjalan 
MAPK melalui fosforilasi protein 42/44. Sebagai kesimpulan, Ficus deltoidea kedua-dua varian berkeupayaan untuk 
merangsang kontraksi uterus melalui mekanisme tapak jalan MAPK.
Kata kunci: Ficus deltoidea; kontraksi otot uterus; Kumpulan Mitogen Activated Protein Kinase (MAPK); 
prostaglandin
INtRODUCtION
labor is the physiological process by which a fetus is 
expelled from the uterus to the outside world and is defined 
as regular uterine contractions accompanied by cervical 
effacement and dilatation (Norwitz et al. 1999). basically, 
the process involves two phases: birth preparation phase 
and the active birth phase (Garfield & yallampalli 1993; 
Chwalisz & Garfield 1994, 1997). Maul et al. (2003) stated 
that active phase involves continued and coordinated 
uterine contractions.
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to expedite the process of a smooth labor requires 
an increase in the coordination of uterine contractions 
along the connective tissue changes in the cervix that 
allows dilatation to occurs the changes are in line with 
simultaneous decline in progesterone level and increase 
in estrogen level (bernal et al. 2003). During pregnancy, 
progesterone maintains the structure of the uterus by 
blocking the production of prostaglandins and inhibits 
gene expression of proteins associated with contraction 
in the myometrium (Challis et al. 2000; Norwitz et al. 
2001). Meanwhile, the birth process involves a variety 
of hormones such as oxytocin and prostaglandins. In 
the early labor stage, oxytocin from the placenta will act 
directly on the myometrium to produce contractions and 
at the same time indirectly increases the production of 
prostaglandin, particularly prostaglandin F2α (Wilson et 
al. 1988). Increased prostaglandin synthesis is important 
for the progression of contractions during labor.
Women who experienced problems in uterine 
contraction may face difficulties during childbirth. to 
overcome this problem, uterotonic agents are often used 
to clinically facilitate delivery. Misoprostol or Cytotec, an 
analogue of prostaglandin E1, is an example of uterotonic 
drug. however, the usage often causes side effects to 
the mother such as hyperpyrexia (Dyer et al. 2010). 
Alternatively, Pitocin that resembles oxytocin activity is 
also used to induce uterine contractions during childbirth. 
the use of such synthetic drugs during labour can also 
provide adverse effects that are not favourable to women’s 
health as well as to the infant. For instance, there was a 
higher relative risk of being diagnosed with depressive or 
anxiety disorder within the first year of postpartum and 
also incidents of jaundice in neonates (Kroll-Desrosiers 
et al. 2017; Garosi et al. 2016).
taken together, the use of complementary and 
alternative medicine has become a favourable choice 
among women worldwide. Studies have shown that 
between 30 to 50% of adults in industrialized countries 
use some form of alternative medicine to prevent or treat 
health problems (Astin 1998). According to Eisenberg et 
al. (1998), 49% of women opted for alternative therapy 
and herbal therapy is a popular choice (Gibson 2001). 
there are many herbs that can be used to stimulate uterine 
contractions during labour. One of them is Ficus deltoidea 
and is also locally known as Mas Cotek. Ficus deltoidea has 
been scientifically proven to stimulate contractions of the 
uterus and is traditionally used by women to contract the 
uterus after delivery (Sulaiman et al. 2008). two variants, F. 
deltoidea var. Deltoidea and F. deltoidea var. Angustifolia 
have been shown to stimulate uterine contractions (Umi 
Romaizatul Amiera et al. 2014). the mechanism of action 
of FDD and FDA in stimulating uterine contractions is yet 
to be investigated. therefore, the aim of this study was to 
elucidate the uterotonic mechanism of FDD and FDA.
MAtERIAlS AND MEthODS
PlANt MAtERIAl
Ficus deltoidea leaves were obtained from Juaseh tengah 
in Negeri Sembilan, Malaysia. the plant samples were 
taxonomically identified, authenticated and deposited at the 
herbarium, Faculty of Science and technology, Universiti 
Kebangsaan Malaysia with voucher number UKMb 29780 
for Ficus deltoidea var. Angustifolia (FDA) and UKMb 
29781 for Ficus deltoidea var. Deltoidea (FDD).
PREPARAtION OF thE ExtRACt
After the leaves were cut into smaller pieces, the leaves were 
extracted with distilled water for 16 hours by using Soxhlet 
apparatus (Fisher Scientific, UK). the aqueous extract was 
filtered and freeze-dried (labconco Corporation, USA) 
until it became lyophilized. the lyophilized powder was 
kept in an air-tight container and kept in the refrigerator 
at 4°C until needed.
ANIMAl
Non-pregnant Sprague Dawley rats (weight 200-250 g) 
were purchased from laboratory Animal Research Unit, 
Faculty of Medicine, Universiti Kebangsaan Malaysia 
(UKM). the rats were supplied with standard laboratory 
pellet diet and water ad libitum. All animal procedures 
were approved by Universiti Kebangsaan Malaysia 
Animal Ethics Committee (UKMAEC No: FSK/bIOMED2011/
NIhAyAh/403-NOV/403-NOV-2011-JUN2014.
UtERINE tISSUE ExPERIMENt
the protocols were obtained from Umi Romaizatul Amiera 
et al. (2014). In short, the non-pregnant female rats were 
injected with 0.2 mg/kg diethylstilbestrol (Sigma Aldrich, 
USA) 24 hours prior to experiment. this was done to induce 
the animals to be in estrus phase. Vaginal smear of the rats 
were done to confirm the stage of the estrous cycle. Once 
the rats were in estrus phase, the rats were killed and the 
uterine horns were taken out. the uterine horn was cleaned 
and cut into 2 cm strips. A strain gauge force transducer 
was sutured to the serosa of the uterine strip and mounted 
in 60 ml organ bath containing tyrode solution aerated 
with 95% O2, 5% CO2 and temperature maintained at 
37°C. the organ bath was then connected to a Powerlab 
system (ADInstruments, Australia). the transducer was 
previously calibrated to establish the association between 
the force applied to the transducer and gauge deflection 
with one gram corresponding weight. the uterine strip was 
allowed to stabilize for 30 min in the organ bath before the 
application of extracts.
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EFFECt OF FICuS DElTOIDEA lEAVES AqUEOUS ExtRACt 
ON UtERINE CONtRACtION
this study was conducted ex vivo on uterine strip of 
rats treated with extracts of FDD and FDA at different 
concentrations ranging from 10 µg/ml to 1280 µg/ml at 
time interval of 5 minutes between doses. the frequency 
and intensity of uterine contractions were detected using 
Powerlab’s Chart 5 software. Maximum contractions for 
both extracts were recorded.
PROStAGlANDIN F2α lEVEl
Uterine samples collected at Emax were homogenized and 
processed accordingly. To determine the level of PGF2α in 
the samples, PGF2α high sensitivity ELISA kit from Enzo 
life Sciences, Inc. (USA) was used. the procedures were 
performed according to the manufacturer’s instructions. 
Absorbance was measured at λ 415 nm.
WEStERN blOttING
the protein concentration was determined via bradford 
assay. homogenate protein was subjected to SDS-PAGE 
and the gel was transferred to polyvinylidenedifluoride 
(PVDF) membrane. blots were probed with phosphorylated 
p42/44 (p42/44) MAPK primary antibody conjugated with 
horse-radish peroxidase (hRP)(Cell Signalling technology, 
USA). the transferred bands were visualized by enhanced 
chemiluminescence.
StAtIStICAl ANAlySIS
Results were analyzed using Software Statistical Package 
for the Social Sciences (SPSS) version 20.0. Statistical 
significance was achieved when p < 0.05. Normality was 
checked, test Analysis of Variance (ANOVA) was used 
followed by post-hoc Dunnett test to compare the statistical 
difference between the groups. Data are presented as mean 
± SEM.
RESUltS
EFFECt OF FICuS DElTOIDEA VAR. DEltOIDEA (FDD) 
AqUEOUS ExtRACt ON thE INtENSIty OF UtERINE 
CONtRACtIONS
the intensity of basal uterine contractions before the 
application of FDD extract was 0.135 ± 0.028 g. the 
intensity of the contractions, however, showed no 
significant increase (p > 0.05) following administration of 
the extract. Maximum uterine contractions or Emax (0.221 
± 0.039 g) was achieved at the concentration of 320 µg/
ml (Figure 1).
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FIGURE 1. Intensity of the uterine contractions before (basal) and after treated with increasing concentration of Ficus deltoidea var. 
Deltoidea aqueous extract. the maximum uterine contraction or Emax for FDD was achieved at 320 µg/ml. Data was extracted from  
n = 6 strips and expressed as mean ± SEM
EFFECt OF FICuS DElTOIDEA VAR. ANGUStIFOlIA (FDA) 
AqUEOUS ExtRACt ON thE INtENSIty OF UtERINE 
CONtRACtIONS
the intensity of basal uterine contractions before starting 
the treatment was 0.354 ± 0.092 g. the intensity of 
the contractions increased moderately following the 
administration of the extract in a dose-dependent manner. 
Maximum uterine contractions or Emax (0.613 ± 0.136 
g) was achieved at the concentration of 960 µg/ml 
(Figure 2).
EFFECt OF FICuS DElTOIDEA AqUEOUS ExtRACt ON 
PROStAGlANDIN F2α lEVEl IN MyOMEtRIUM OF UtERUS
based on the findings, there was no significant increase in 
PGF2α levels compared with basal contractions (p > 0.05) 
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(Figure 3). The level of PGF2α during basal contraction 
was 8.12 ± 1.32 pg/ml, FDD was 9.30 ± 0.23 pg/ml and FDA 
was 9.45 ± 0.20 pg/ml.
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FIGURE 2. Intensity of the uterine contractions at basal and after treated with increasing concentration of Ficus deltoidea var. 
Angustifolia (FDA) aqueous extract at 5 minutes interval. Note that Emax for FDA was cumulatively achieved at 960 µg/ml. Data was 
extracted from n = 6 strips and expressed as mean ± SEM
FIGURE 3. Level of PGF2α basal contractions (basal), at 
maximum uterine contractions (Emax) induced by FDD at 320 
ug/ml) and FDA at 960 ug/ml. Data was extracted from n = 3 
strips and expressed as mean ± SEM
EFFECt OF FICuS DElTOIDEA AqUEOUS ExtRACtS ON thE 
ExPRESSION OF PhOSPhORylAtED P42/44 (P42/44)
there was a notable increase in the density of phosphorylated 
p42/44 protein bands produced in FDD- and FDA-
induced myometrium contractions compared to the basal 
contraction (Figure 4A). Further analysis revealed that, 
upon normalization to the β-actin expression, FDD extract 
caused a 2.4-fold increase in the relative intensity of 
phosphorylated p42/44 protein expression compared to 
the basal contractions (p > 0.05) (Figure 4b). however, 
FDA extract caused a significant 3.8-fold increase in the 
relative expression of phosphorylated p42/44 compared 
to the expression of the same protein at basal contractions 
(p < 0.05).
DISCUSSION
the study was carried out ex vivo, to assess concentration-
response relationship of Ficus deltoidea var. Deltoidea 
(FDD) and Ficus deltoidea var. Angustifolia (FDA) aqueous 
extracts in contractile tissues of isolated rats’ uterus. based 
on the results obtained, the increased in the intensities of 
the uterine contraction were not significant following FDD 
and FDA extracts administrations (p > 0.05). however, there 
were trends of dose-dependent increase in the contraction 
intensities observed for FDA extract but not for FDD. Despite 
that, maximum contraction or Emax was achieved at 320 
µg/ml for FDD, and 960 µg/ml for FDA. Umi Romaizatul 
Amiera et al. (2014) reported Emax concentrations of 640 µg/
ml for FDD and 20 µg/ml for FDA, whereas Naguib & Vivi 
Noryati (2013) reported 2 mg/ml as the Emax concentration 
for FDA. the discrepancies might be due to the difference 
in the preparation of the extract itself as the methodology 
employed was not similar, thus, affecting the type, amount 
or concentration of constituents present in the extract. 
Despite the discrepancies in the concentrations that caused 
maximum contraction for the range of concentrations used, 
both FDD and FDD in the current study did show uterotonic 
activities similar to other reported Ficus sp. (bafor et al. 
2009; Watcho et al. 2011; bafor et al. 2010; Naguib & Vivi 
Noryati 2013, Umi Romaizatul Amiera et al. 2014). there 
are several basis for the uterine-stimulating activities shown 
by both FDD and FDA. Phytochemical content presence in 
the plants contributes greatly to the reported biological 
functions. For instance, flavonoids and tannin compounds, 
as in the aqueous extracts of FDD and FDA, have been 
reported to contribute to the uterotonic effects (Calixto et 
al. 1986; Umi Romaizatul Amiera et al. 2014). Flavonoids 
are also a type of phytoestrogen which are similar to 
estradiol or synthetic estrogens (Kurzer & xu 1997; 
Moon et al. 2006). Phytoestrogens can activate estrogen 
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receptors presence in the nucleus to produce estrogenic 
activities including uterine contractions (Anderson et al. 
1999). based on previous studies, Radix trichosanthis 
was found to amplify spontaneous uterine contractions in 
vivo and increased uterine muscle response to PGF2α and 
oxytocin in pseudopregnant rabbits (Chen & Chu 1993). 
It is believed that all phytoestrogens are able to influence 
the frequency and intensity of myometrial contractions, 
and depending on the concentrations may sometimes 
cause weak contractions or show weak estrogenic activity 
(Setchell & Cassidy, 1999; Picherit et al. 2000).
In the current study, the level of prostaglandin F2-alpha 
(PGF2α) was investigated to determine the involvement of 
PGF2α in uterine muscle contractions induced by FDD and 
FDA extracts. PGF2α is the second most potent uterotonin 
after oxytocin (Naguib & Vivi Noryati 2013) the current 
results showed that PGF2α was also expressed in non-
induced uterine tissues, suggesting its function in regulating 
spontaneous basal contractions and other endometrial 
functions (Kupittayanant et al. 2014; blesson & Sahlin 
2014). though not significant, slight increase in the level 
of PGF2α upon maximum contractions (Emax) induced 
by FDD and FDD extracts suggest the involvement of 
prostaglandin in uterine muscle contraction. Naguib & Vivi 
Noryati (2013) reported that FDA-induced contraction was 
mediated via uterotonic receptors that include muscarinic, 
oxytocin and PGF2α receptors. In the current study, the 
level quantitated was PGF2α protein and not the receptors. 
therefore it is possible that uterine muscle contractions 
induced by FDD and FDA stimulate endogenous myometrial 
synthesis of PGF2α that later bound to PGF2α receptors 
to activate downstream signalling (Naguib & Vivi Noryati 
2013). Oxytocin is also able to stimulate endometrial 
secretion of endogenous PGF2α to effectively increase 
the uterine contractions by promoting a more forceful 
contraction (Carnahan et al. 1996; Dittrich et al. 2009, 
Arrowsmith et al. 2010). Other than that, estrogen also has 
been reported to increase PGF2α production that in turn 
has direct stimulation on uterine contractions (Egarter & 
husslein 1982). In the estrus phase, estrogen level is high. 
Thus, the capacity to synthesize and secrete uterine PGF2α 
is increased during this period due to increased level of 
estrogen and decrease level of progesterone. Estrogen 
regulates expression of endometrial prostaglandin G/h 
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FIGURE 4. the intensity of phosphorylated p42/44 protein bands in the uterine strips at 3 different statuses; basal, FDD (320 µg/ml), 
FDA (960 µg/ml). Note the increase in the band intensities of p42/44 at the maximum uterine contractions when treated with FDD 
and FDA extracts compared to the p42/44 expression at basal contractions (Figure 4A). At maximum contraction, administration of 
FDA extract caused a significant 3.8-fold increase in the expression of p42/44 protein expression compared to the basal contractions 
(Figure 4b). Data was extracted from n = 3 strips and expressed as mean ± SEM
Chap 11.indd   79 31/05/2018   15:29:02
80
synthase 1 (PGhS-11), also known as cyclooxygenase-1 
(COX-1), thereby stimulating the synthesis of PGF2α by 
the uterus (barcikowski et al. 1974).
PGF2α activates MAPKs through stimulation of G 
proteins, either Gαq/11 or Gαi. According to harbon et al. 
(1984), PGF2α binds to prostaglandin receptor (FP) through 
stimulation of Gαq/11 which then produces rapid intracellular 
signal transduction and stimulates phospholipase C (PlC). 
PlC catalyzes the hydrolysis of phosphatidylinositol 
biphosphate (PIP2). Subsequently PIP2 produces inositol 
1,4,5-triphosphate (IP3) and diacylglycerol (DG). Next, 
DG activates protein kinase C (PKC) and undergoes several 
steps to activate Mitogen Activated Protein Kinases 
(MAPKs) through phosphorylation of p42/44 protein. 
Ohmichi et al. (1997) stated that PGF2α has been reported 
to activate MAPK in rat myometrium cell cultures. based on 
the results of the current study, there was an increase in the 
density of phosphorylated p42/44 protein bands produced 
in the uterus treated with FDD and FDA compared to the 
basal contractions. Phytochemical screening of the leaves 
for both plants revealed the presence of terpenoids in FDA 
aqueous extract (Umi Romaizatul Amiera et al. 2014). this 
compound also has been implicated as chemical stimuli 
that can trigger smooth muscle contraction (Rezaeizadeh 
et al. 2016; Sommer et al. 2017). however, the exact role 
of terpenoids and its association with increased expression 
level of phosphorylated p42/44 MAPK protein is not known. 
Studies by Watts (1996) stated that p42/44 play a major role 
in regulating smooth muscle contraction in rats. Previous 
studies have suggested that p42/44 stimulate smooth muscle 
contraction through a thin filament regulatory pathway by 
phosphorylation of caldesmon (CAD), regulatory proteins 
that play a role in smooth muscle contraction (Adam et 
al. 1995; horowitz et al. 1996; Morgan & Gangopadhyay 
2001). 
the results of the current study showed that FDD and 
FDA aqueous extracts both increased uterine contractions 
of rats ex vivo. both FDD and FDA caused increased level of 
PGF2α during uterine contractions. Both Ficus deltoidea 
aqueous extract increased the contractions of the uterus 
through MAPK pathway with increased phosphorylated 
p42/44 expression compared to normal contractions.
CONClUSION
Ficus deltoidea-induced uterotonic effect is related to the 
release of prostaglandin and contraction of the myometrial 
cells through phosphorylated p42/44 MAP kinase activation. 
these findings provide scientific basis to the ethnic use of 
F. deltoidea for its uterotonic properties.
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